New findings from researchers at Cleveland Clinic have revealed that bacteria in tumors from patients with young-onset colorectal cancer are compositionally distinct, which could help inform targeted approaches to screening and treatments.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
